Testing criterion-based benchmarking for the appropriate use of radiotherapy

被引:7
作者
Barton, Michael B. [1 ,2 ]
Gabriel, Gabriel S. [1 ,2 ]
Delaney, Geoffrey P. [1 ,2 ]
机构
[1] Univ New South Wales, Sydney, NSW, Australia
[2] Ingham Inst Appl Med Res, CCORE, Liverpool, Australia
关键词
Radiotherapy utilisation; Benchmarking; GENERAL-POPULATION; BREAST-CANCER; RADIATION-THERAPY; PROSTATE-CANCER; LUNG-CANCER; NEED;
D O I
10.1016/j.radonc.2018.05.023
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Planning for radiotherapy (RT) services requires information on the proportion of patients who should be given radiotherapy. Criterion-Based Benchmark (CBB) has been proposed in Canada to estimate the proportion of cancer patients who should be treated with radiotherapy. The aim of this study was to assess CBB in a health system outside of Canada. Methods: Radiotherapy data for all new cases of cancer in New South Wales (NSW), and the Australian Capital Territory (ACT) Australia in 2004-06 and were linked to Central Cancer Registry records. Road distances between patient residence and the nearest RT centre were calculated. Local Government Areas (LGAs) with public radiotherapy departments were selected as CBB LGAs if they met the following criteria: 1. Patients make no direct payment for radiotherapy. 2. All RT is provided by site-specialised radiation oncologists in multi-disciplinary centres. 3. Radiation oncologists receive salary for their service. 4. More than 75% of patients live within 30 km from the nearest RT, and 5. Patients' waiting times were <4 weeks. Results: 25,383 (26%) out of 98,000 eligible patients in NSW and ACT received radiotherapy in the study period as part of their initial treatment. An average of 31% of patients in the CBB LGAs received radiotherapy compared to an average of 26% in all LGAs during the study period. Discussion: NSW-ACT RT utilisation for selected tumour sites was 7-16% higher in the CBB LGAs than in all LGAs, but was still 30-65% below the estimated optimal radiotherapy utilisation rates and differed significantly from Canadian CBBs. CBB is based on the assumption that there is perfect service delivery in some parts of the health service that can be used to benchmark the whole service. It may be applicable in well-resourced publicly-funded services in Canada, but the CBB approach may not be reproducible in other jurisdictions. (C) 2018 Elsevier B.V. All rights reserved.
引用
收藏
页码:406 / 410
页数:5
相关论文
共 21 条
[1]   Expanding global access to radiotherapy [J].
Atun, Rifat ;
Jaffray, David A. ;
Barton, Michael B. ;
Bray, Freddie ;
Baumann, Michael ;
Vikram, Bhadrasain ;
Hanna, Timothy P. ;
Knaul, Felicia M. ;
Lievens, Yolande ;
Lui, Tracey Y. M. ;
Milosevic, Michael ;
O'Sullivan, Brian ;
Rodin, Danielle L. ;
Rosenblatt, Eduardo ;
Van Dyk, Jacob ;
Yap, Mei Ling ;
Zubizarreta, Eduardo ;
Gospodarowicz, Mary .
LANCET ONCOLOGY, 2015, 16 (10) :1153-1186
[2]  
Australian Institute of Health and Welfare, 2017, 191 HSE AUSTR I HLTH
[3]   Defining the need for radiotherapy for lung cancer in the general population - A criterion-based, benchmarking approach [J].
Barbera, L ;
Zhang-Salomons, J ;
Huang, J ;
Tyldesley, S ;
Mackillop, W .
MEDICAL CARE, 2003, 41 (09) :1074-1085
[4]  
Barton MB, 2014, RADIOTHERAPY ONCOL
[5]  
Borras JM, 2015, RADIOTHERAPY ONCOL
[6]   The role of radiotherapy in cancer treatment - Estimating optimal utilization from a review of evidence-based clinical guidelines [J].
Delaney, G ;
Jacob, S ;
Featherstone, C ;
Barton, M .
CANCER, 2005, 104 (06) :1129-1137
[7]   An evidence-based estimate of the appropriate radiotherapy utilization rate for colorectal cancer [J].
Foroudi, F ;
Tyldesley, S ;
Barbera, L ;
Huang, J ;
Mackillop, WJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (05) :1295-1307
[8]   Evidence-based estimate of appropriate radiotherapy utilization rate for prostate cancer [J].
Foroudi, F ;
Tyldesley, S ;
Barbera, L ;
Huang, J ;
Mackillop, WJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 55 (01) :51-63
[9]   An evidence-based estimate of appropriate radiotherapy utilization rate for breast cancer [J].
Foroudi, F ;
Tyldesley, SR ;
Walker, H ;
Mackillop, WJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 53 (05) :1240-1253
[10]  
Gabriel G., 2014, THESIS